American Capital Advisory’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
BIP
American Capital Advisory's TAK Position: Q2 2026 in Review
American Capital Advisory increased its Takeda Pharmaceutical (TAK) stake by 24% in Q2 2026, buying an estimated $563 and bringing the position to 177 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #549.
American Capital Advisory first reported a position in TAK in Q3 2025 and has held it in 4 quarters since. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- American Capital Advisory held 177 shares of Takeda Pharmaceutical worth $2.84K as of Q2 2026.
- American Capital Advisory bought 34 Takeda Pharmaceutical shares in Q2 2026, an estimated $563.
- Takeda Pharmaceutical made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #549 holding.
- American Capital Advisory first reported a position in Takeda Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
- 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.